Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes

Vaccine

Volumn 26, Issue 49, 2008, Pages 6274-6280

  Lei, Liancheng ^a,b   Sun, Changjiang ^a   Lu, Shuang ^a   Feng, Xin ^a   Wang, Jiaqi ^b   Han, Wenyu ^a  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Actinobacillus pleuropneumoniae; Heterologous immunization; Propionibacterium acnes; Vaccine candidate gene

Indexed keywords

BACTERIAL VACCINE; COMPLEMENTARY DNA;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SEROTYPE; SURVIVAL RATE; SWINE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOTTING, SOUTHERN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DRUG EVALUATION, PRECLINICAL; FEMALE; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; MALE; MICE; PLASMIDS; PROPIONIBACTERIUM ACNES; RIBOSOMES; SWINE; SWINE DISEASES; VACCINES, DNA;

EID: 55549122644     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.039     Document Type: Article

References (31)

1. Fenwick B., and Henry S. Porcine pleuropneumonia. J Am Vet Med Assoc 204 9 (1994) 1334-1340
2. Velthuis A.G., De Jong M.C., Stockhofe N., Vermeulen T.M., and Kamp E.M. Transmission of Actinobacillus pleuropneumoniae in pigs characterized by variation in infectivity. Epidemiol Infect 129 1 (August) (2002) 203-214
3. Losinger W.C. Economic impacts of reduced pork production associated with the diagnosis of Actinobacillus pleuropneumoniae on grower/finisher swine operations in the United States. Prev Vet Med 68 2-4 (2005) 181-193
4. Blackall P.J., Klaasen H.L., van den Bosch H., Kuhnert P., and Frey J. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet Microbiol 84 1-2 (2002) 47-52
5. Bei W., He Q., Yan L., Fang L., Tan Y., Xiao S., et al. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol Lett 243 1 (2005) 21-27
6. Cruijsen T., van Leengoed L.A., Ham-Hoffies M., and Verheijden J.H. Convalescent pigs are protected completely against infection with a homologous Actinobacillus pleuropneumoniae strain but incompletely against a heterologous-serotype strain. Infect Immun 63 6 (1995) 2341-2343
7. Chiers K., van Overbeke I., De Laender P., Ducatelle R., Carel S., and Haesebrouck F. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins. Vet Q 20 2 (1998) 65-69
8. Hensel A., Huter V., Katinger A., Raza P., Strnistschie C., Roesler U., et al. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 18 26 (2000) 2945-2955
9. Katinger A., Lubitz W., Szostak M.P., Stadler M., Klein R., Indra A., et al. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. J Biotechnol 73 2-3 (1999) 251-260
10. Goethe R., Gonzales O.F., Lindner T., and Gerlach G.F. A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction. Vaccine 19 7-8 (2000) 966-975
11. Rioux S., Girard C., Dubreuil J.D., and Jacques M. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs. Res Vet Sci 65 2 (1998) 165-167
12. Bagdasarian M.M., Nagai M., Frey J., and Bagdasarian M. Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit. Vaccine 17 5 (1999) 441-447
13. Maas A., Meens J., Baltes N., Hennig-Pauka I., and Gerlach G.F. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection. Vaccine 24 49-50 (2006) 7226-7237
14. Lee K.Y., Kim D.H., Kang T.J., Kim J., Chung G.H., Yoo H.S., et al. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol Med Microbiol 48 3 (2006) 381-389
15. Maas A., Jacobsen I.D., Meens J., and Gerlach G.F. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Infect Immun 74 7 (2006) 4124-4132
16. Hensel A., Stockhofe-Zurwieden N., Petzoldt K., and Lubitz W. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge. J Infect Immun 63 8 (1995) 3048-3053
17. van den Bosch H., and Frey J. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. Vaccine 21 25-26 (2003) 3601-3607
18. Xu F., Chen X., Shi A., Yang B., Wang J., Li Y., et al. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae. Vet Microbiol 118 3-4 (2006) 230-239
19. Prideaux C.T., Lenghaus C., Krywult J., and Hodgson A.L. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Infect Immun 67 4 (1999) 1962-1966
20. Tumamao J.Q., Bowles R.E., van den Bosch H., Klaasen H.L., Fenwick B.W., Storie G.J., et al. Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine. Aust Vet J 82 6 (2004) 370-374
21. Wagner T.K., and Mulks M.H. Identification of the Actinobacillus pleuropneumoniae leucine-responsive regulatory protein and its involvement in the regulation of in vivo-induced genes. Infect Immun 75 1 (2007) 91-103
22. Becker P., Hufnagle W., Peters G., and Herrmann M. Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl Environ Microbiol 67 7 (2001) 2958-2965
23. Lisitsyn N., and Wigler M. Cloning the differences between two complex genomes. Science 259 5097 (1993) 946-951
24. Villemagne D., Jackson R., and Douthwaite J.A. Highly efficient ribosome display selection by use of purified components for in vitro translation. J Immunol Methods 313 1-2 (2006) 140-148
25. Lancashire J.F., Turni C., Blackall P.J., and Jennings M.P. Rapid and efficient screening of a representational difference analysis library using reverse Southern hybridisation: identification of genetic differences between Haemophilus parasuis isolates. J Microbiol Methods 68 2 (2007) 326-330
26. Fuller T.E., Thacker B.J., Duran C.O., and Mulks M.H. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine. Vaccine 18 25 (2000) 2867-2877
27. Hannan P.C., Bhogal B.S., and Fish J.P. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci 33 1 (1982) 76-88
28. Lin L., Bei W., Sha Y., Liu J., Guo Y., Liu W., et al. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. FEMS Microbiol Lett 274 1 (2007) 55-62
29. Braga E.G., Ananias R.Z., Mussalem J.S., Squaiella C.C., Longhini A.L., Mariano M., et al. Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice. Immunol Lett 88 2 (2003) 163-169
30. Jung Y.S., Matsumoto S.E., Yamashita M., Tomimatsu K., Teruya K., Katakura Y., et al. Propionibacterium acnes acts as an adjuvant in in vitro immunization of human peripheral blood mononuclear cells. Biosci Biotechnol Biochem 71 8 (2007) 1963-1969
31. Mussalem J.S., Vasconcelos J.R., Squaiella C.C., Ananias R.Z., Braga E.G., Rodrigues M.M., et al. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene. Microbiol Immunol 50 4 (2006) 253-263